期刊文献+

骨质疏松性骨折药物治疗的临床分析 被引量:7

下载PDF
导出
摘要 目的 分析使用药物治疗骨质疏松性骨折的临床疗效.方法 选取我院2008年6月-2012年2月收治的80例骨质疏松性骨折患者,采用药物治疗,患者在补钙的同时服用降钙素和骨化三醇,在药物治疗0.5~1.0年后检查骨密度变化、骨折情况和疼痛强度,进行疗效分析.结果 患者治疗期间均未发生骨折,治疗前骨密度值0.70~0.74 g/cm2,平均(0.72±0.10)g/cm2 ;治疗后骨密度值0.72~0.76 g/cm2,平均(0.74±0.11)g/cm2.治疗前后骨密度值比较,差异有统计学意义(P<0.05).治疗前疼痛评分2.4~9.6分,平均(6.4±2.1)分;治疗后疼痛评分1.0~4.6分,平均(2.1±0.9)分.治疗前后疼痛评分比较,差异有统计学意义(P<0.05).结论 骨质疏松性骨折采用降钙素、骨化三醇和钙剂治疗能够增加患者的骨密度,减轻疼痛,值得临床应用.
作者 李智明
出处 《临床合理用药杂志》 2014年第3期51-52,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献5

二级参考文献26

  • 1娄明武,范义,朴荣日,胡卫东,王秀荣.骨质疏松与病理性骨折的相关性研究[J].中国骨质疏松杂志,2006,12(4):330-332. 被引量:8
  • 2RYMER J, ROBINSON J, FOGELMAN I. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausa| bone loss [ J ] .Osteoporos Int, 2001,12 (6) : 478-483.
  • 3BROWN J P, KENDLER D L, McCLUNG M R, et al. The ef- ficacy and tolerability of risedronate once a week for the treat- ment of postmenopausal osteoporosis [J].Calcif Tissue Int, 2002,71 (2) : 103-111.
  • 4DE GROEN P C, LUBBE D F, HIRSCH L J, et al. Esophagi- tis associated with the use of alendronate [J ].N Engl J Med, 1996,335(14): 1016-1021.
  • 5HODSMAN A B, KISIEL M, ADACHI J D, et al. Histomor- phometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1-34) therapy in women with severe osteoporosis [J].Bone, 2000,27(2) :311-318.
  • 6YANG N N, VENUGOPALAN M, HARDIKAR S, et al. I- dentification of an estrogen response element activated by metabolites of 17 β-estradiol and raloxifene [J].Science, 1996,273 (5279) : 1222- 1225.
  • 7LINDSAY R, COSMAN F, LOBO R A, et al. Addition of al- endronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial [ J ]. J Clin Endocrinol Metab, 1999,84 (9) : 3076-3081.
  • 8JOHNELL O, SCHEELE W, LU Y, et al. Effects of raloxifene (RLX) ,alendronate (ALN) and RLX + ALN on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal women with osteoporosis [J].J Bone Miner Res, 1999,14(Suppl 1) :S157.
  • 9COSMAN F, NIEVES J, WOELFERT L, et al. Parathyroid hormone added to established hormone therapy: effects on ver- tebral fracture and maintenance of bone mass after parathyroid hormone withdrawal [ J ] .J Bone Miner Res, 2001 , 16 ( 5 ) : 925- 931.
  • 10Kains JA,Blaek D,Cooper C,et al. International osteoporosis founda- tion and the national osteoporosis foundation, USA. A new approach to the development of assessment guidelines for ostenporosis [J]. Osteoropros Int, 2002,13(7) : 527-536.

共引文献55

同被引文献60

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部